Wave Life Sciences Ltd. Stock
Wave Life Sciences Ltd. Stock price
Key metrics
| Market capitalization | $1.11b |
| Enterprise Value | $865.14m |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| EV/Sales (TTM) EV/Sales | 8.24 |
| P/S ratio (TTM) P/S ratio | 10.56 |
| P/B ratio (TTM) P/B ratio | 6.17 |
| Revenue growth (TTM) Revenue growth | -7.06% |
| Revenue (TTM) Revenue | $104.94m |
Is Wave Life Sciences Ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,842 stocks worldwide.
Wave Life Sciences Ltd. Stock Analysis
Analyst Opinions
13 Analysts have issued a Wave Life Sciences Ltd. forecast:
Analyst Opinions
13 Analysts have issued a Wave Life Sciences Ltd. forecast:
Financial data from Wave Life Sciences Ltd.
| Mar '25 |
+/-
%
|
||
| Revenue | 105 105 |
7%
7%
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | -122 -122 |
81%
81%
|
EBIT (Operating Income) EBIT | -126 -126 |
74%
74%
|
| Net Profit | -112 -112 |
82%
82%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Wave Life Sciences Ltd. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Wave Life Sciences Ltd. Stock News
Company Profile
Wave Life Sciences Ltd. is a biotechnology company, which engages in the development of proprietary synthetic chemistry drug. It focuses on the design, development, and commercialization of nucleic acid-based therapeutics. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.
| Head office | Singapore |
| CEO | Paul Bolno |
| Employees | 288 |
| Founded | 2012 |
| Website | www.wavelifesciences.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
